Tech Company Financing Transactions
Pneumagen Funding Round
On 6/1/2023, Pneumagen raised $8 million in funding from Esperante Ventures, Scottish Enterprise and Thairm Bio.
Transaction Overview
Company Name
Announced On
6/1/2023
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Proceeds Purpose
The company will use the funds to accelerate Phase 2 clinical development of Neumifil for the prevention & treatment of viral respiratory tract infections.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Kinburn Castle, Doubledykes Road
St. Andrews, KY16 9DR
UK
St. Andrews, KY16 9DR
UK
Phone
Undisclosed
Website
Email Address
Overview
PNEUMAGEN LIMITED is a biotechnology company based out of St. Andrews, Scotland.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Douglas Thomson
Browse more venture capital transactions:
Prev: 6/1/2023: Ariga venture capital transaction
Next: 6/1/2023: Galvanick venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs